Glucose availability is a decisive factor for Nrf2-mediated gene expression

Redox Biology

Volumn 1, Issue 1, 2013, Pages 359-365

  Heiss, Elke H ^a   Schachner, Daniel ^a   Zimmermann, Kristin ^a   Dirsch, Verena M ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Glucose addiction; Nrf2; ROS detoxification

Indexed keywords

GLUTATHIONE REDUCTASE; HEME OXYGENASE 1; KELCH LIKE ECH ASSOCIATED PROTEIN 1; PENTOSE PHOSPHATE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SULFORAPHANE; TRANSCRIPTION FACTOR NRF2; CYTOSKELETON PROTEIN; GLUCOSE; ISOTHIOCYANIC ACID DERIVATIVE; KEAP1 PROTEIN, MOUSE; NFE2L2 PROTEIN, MOUSE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SULFORAFAN;

ANAEROBIC GLYCOLYSIS; ANIMAL CELL; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DETOXIFICATION; EMBRYO; FIBROBLAST; GENE EXPRESSION; GENE INACTIVATION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; ANIMAL; CELL CULTURE; GENE SILENCING; GENETICS; METABOLISM; PENTOSE PHOSPHATE CYCLE;

MAMMALIA;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELLS, CULTURED; CYTOSKELETAL PROTEINS; FIBROBLASTS; GENE KNOCKDOWN TECHNIQUES; GLUCOSE; ISOTHIOCYANATES; MICE; NADP; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PENTOSE PHOSPHATE PATHWAY;

EID: 84880782115     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2013.06.001     Document Type: Article

References (18)

1. Bryan H.K., Olayanju A., Goldring C.E., Park B.K. The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation. Biochemical Pharmacology 2013, 85:705-717.
2. Kensler T.W., Wakabayashi N., Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annual Review of Pharmacology and Toxicology 2007, 47:89-116.
3. Copple I.M. The Keap1-Nrf2 cell defense pathway- a promising therapeutic target. Advances in Pharmacology 2012, 63:43-67.
4. Jeong W.S., Jun M., Kong A.N. Nrf2: a potential molecular target for cancer chemoprevention by natural compounds. Antioxidants & Redox Signaling 2006, 8:99-106.
5. Yates M.S., Tran T.W., Dolan Q.T., Osburn P.M., Shin W.O., McCulloc S., Silkworth C.C., takuchi J.B., Yamamoto M., William C.R., Liby K.T., Sporn M.B., Sutter T.R., Kensler T. Genetic vesrus cehmoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap knockout and triterpenoid-treated mice. Carcinogenesis 2009, 30:1024-1031.
6. Shin S., Wakabayashi N., Misra V., Biswal S., Lee G.H., Agoston E.S., Yamamoto M., Kensler T.W. NRF2 modulates arylhydrocarbon receptor signaling: influence on adipogenesis. Molecular and Cellular Biology 2007, 27:7188-7197.
7. Shin S., Wakabayashi J., Yates M.S., Wkabaysahi N., Dolan P.M., Aja S., Liby K.T., Sporn M.B., Yamamoto M., Kensler T.W. Role of Nrf2 in prevention of high-fat diet induced obesity by synthetic triterpenoid CDDO-IM. European Journal of Pharmacology 2009, 620:138-142.
8. Pi J., Leung L., Wang W., Hou Y., Liu D., Yehuda-Shnaidman E., Lee C., Lua J., Kurtz T.W., Chang J.Y. Deficiency of Nrf2 results in impaired adipogenesis and protects against diet-induced obesity. Journal of Biological Chemistry 2010, 285:9292-9300.
9. Mitsuishi Y., Takuchi K., Kawatani Y., Shibata T., Nukiwa T., Aburatani H., Yamamoto M., Motohashi H. Nrf2 redirects glucose and glutamine into anabolic pathways I metabolic reprogramming. Cancer Cell 2012, 22:66-79.
10. Dinkova-Kostova A.T., Kostov R.V. Glucosinolates and isothiocyanates in health and disease. Trends in Molecular Medicine 2012, 18:337-347.
11. Hamilton N.M., Dawson M., Fairweather E.E., Hamilstin N.S., Hitchin J.R., James D.I., Jones S.D., Jordan A.M., Lyons A.J., Samll H.F., Thomson G.J., Wadell I.D., Ogilvie D.J. Novel steroid inhibitors of glucose 6-phosphate dehydrogenase. Journal of Medicinal Chemistry 2012, 55:4431-4445.
12. Metallo C.M., Vander Heiden M.G. Metabolism strikes back: metabolic flux regulates cell signaling. Genes & Development 2010, 24:2717-2722.
13. Krüger A., Grüning N.M., Wamelink M.M., Kerick M., Kirpy A., Parkhomchuk D., Bluemlein K., Schweiger M.R., Soldatov A., Lehrach H., Jakobs C., Ralser M. The pentose phosphate pathway is a metabolic redox sensor and regulates transcription during the antioxidant response. Antioxidants & Redox Signaling 2011, 15:311-324.
14. Wang X., Wu H., Chen H., Liu R., Liu J., Zhang T., Yu W., Hai C. Does insulin bolster antioxidant defenses via the extracellular signal-regulated kinases-protein kinase B-nuclear factor erythroid 2 p45 related factor 2 pathway?. Antioxidants & Redox Signaling 2012, 15:1061-1070.
15. Uruno A., Furusawa Y., Yagishita Y., Fukutomi T., Muramatsu H., Negishi T., Sugawara A., Kensler T.W., Yamamoto M. The Keap1-Nrf2 system prevents onset of diabetes mellitus. Molecular and Cellular Biology 2013, 33:2996-3010.
16. Tanaka Y., Aleksunes L.M., Yeager R.L., Gyamfi M.A., Esterly N., Guo G.L., Klaassen C.D. NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet. Journal of Pharmacology and Experimental Therapeutics 2008, 325:655-664.
17. Aleksunes L.M., Reisman S.A., Yeager R.L., Goedken M.J., Klaassen C.D. Nuclear factor erythroid 2-related factor 2 depletion impairs glucose tolerance and exacerbates hyperglycemia in type 1 diabetic mice. Journal of Pharmacology and Experimental Therapeutics 2010, 333:140-151.
18. Yu Z., Shao W., Chiang Y., Foltz W., Zhang Z., Ling W., Fantus I.G., Jin T. Oltipraz upregulates the nuclear factor ( erythroid-derived 2)-like 2 (NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL/6J mice. Diabetologia 2011, 54:922-934.